| Views | |
|---|---|
| Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia | 141 |
| February 2026 | March 2026 | April 2026 | May 2026 | June 2026 | July 2026 | August 2026 | |
|---|---|---|---|---|---|---|---|
| Correction of morphofunctional disorders of the cardiovascular system with asialized erythropoietin and arginase II selective inhibitors KUD 974 and KUD 259 in experimental preeclampsia | 4 | 1 | 2 | 8 | 0 | 6 | 2 |
| Views | |
|---|---|
| Lokteva_Correction.pdf | 72 |
| Views | |
|---|---|
| United States | 43 |
| Canada | 22 |
| China | 6 |
| Germany | 6 |
| Vietnam | 6 |
| Brazil | 3 |
| India | 3 |
| Switzerland | 2 |
| Russia | 2 |
| A2 | 1 |
| Views | |
|---|---|
| Ottawa | 22 |
| Houston | 5 |
| Mountain View | 5 |
| Beijing | 4 |
| Mumbai | 3 |
| San Francisco | 3 |
| Washington | 3 |
| White Plains | 3 |
| Baltimore | 2 |
| Englewood | 2 |